The effect of thyroid hormone supplementation on hemodynamic stability and survival in an endotoxin-induced model of physiologic stress

Journal of Surgical Research

Volumn 61, Issue 1, 1996, Pages 77-83

  Glembot, Troy M ^a   Hill, Michael A ^a   Britt, L D ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; ENDOTOXIN; LIOTHYRONINE; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; HEMODYNAMICS; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN TISSUE; INTERNAL JUGULAR VEIN; INTRAVENOUS DRUG ADMINISTRATION; LIOTHYRONINE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; SURVIVAL; THYROXINE BLOOD LEVEL;

EID: 0030021864     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0084     Document Type: Article

References (34)

1. Becker, R. A., Vaughan, G. M., Goodwin, C. W., Ziegler, M. G., Harrison, T. S., Mason, A. D., and Pruitt, B. A. Plasma norepinephrine, and thyroid hormone interactions in severely burned patients. Arch. Surg. 115: 439, 1980.
2. Baue, A. E., Gunther, B., Hartl, W., Ackenheil, M., and Herberer, G. Altered hormonal activity in severely ill patients after injury or sepsis. Arch. Surg. 119: 1125, 1984.
3. Kakucska, I., Romero, L. I., Clark, B. D., Rondeel, J. M. M., Qi, Y., Alex, S., Emerson, C. H., and Lechan, R. M. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: Implications for nonthyroidal illness. Neuroendocrinology 59: 129, 1994.
4. 3 in critically ill, thermally injured patients. J. Trauma 20(9): 713, 1980.
5. Williams, R. H., Jaffe, H., and Kemp, C. Effect of severe stress upon thyroid function. Am. J. Physiol. 159: 291, 1949.
6. Utiger, R. D. Decrease extrathyroidal triiodothyronine production in nonthyroidal illness: Benefit or harm? Am. J. Med. 69: 807, 1980.
7. Elson, M. K., Oken, M. M., and Shafer, R. B. Effect of endotoxin fever on plasma clearance of thyroxine and tri-iodothyronine: Concise communication. J. Nuclear Med. 23: 241, 1982.
8. Vagenakis, A. G., Burger, A., Portnay, G. I., Rudolph, M., O'Brian, J. T., Azizi, F., Arky, R. A., Nicod, P., Ingbar, S. H., and Braverman, L. E. Diversion of peripheral thyroxin metabolism from activating to inactivating pathways during complete fasting. J. Clin. Endocrinol. Metab. 41: 191, 1975.
9. Portnay, G. I., O'Brian, J. T., Bush, J., Vagenakis, A. G., Azizi, F., Arky, R. A., Ingbar, S. H., and Braverman, L. E. The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J. Clin. Endocrinol. Metab. 39: 191, 1974.
10. Hesch, R. D., Husch, M., Kodding, R., Hoffken, B., and Meyer, T. Treatment of dopamine-dependent shock with triiodothyronine. Endocr. Res. Commun. 8(4): 229, 1981.
11. Little, J. S. Effect of thyroid hormone supplementation on survival after bacterial infection. Endocrinology 117(4): 1431, 1985.
12. Brent, G. A., and Hershman, J. M. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J. Clin. Endocrinol. Metab. 63(1): 1, 1986.
13. Howlett, T. A., Keogh, A. M., Perry, L., Touzel, R., and Rees, L. H. Anterior and posterior pituitary function in brain-stem-dead donors. Transplantation 47(5): 828, 1989.
14. 3 preserves respiratory function in sepsis. J. Trauma 31(6): 753, 1991.
15. Dulchavsky, S. A., and Bailey, J. Triiodothyronine treatment maintains surfactant synthesis during sepsis. Surgery 112(2): 475, 1992.
16. van der Poll, T., Van Zee, K. J., Endert, E., Coyle, S. M., Stiles, D. M., Pribble, J. P., Catalano, M. A., Moldawer, L. L., and Lowry, S. F. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J. Clin. Endocrinol. Metab. 80: 1341, 1995.
17. van der Poll, T., Romijn, J. A., Wiersinga, W. M., and Sauerwein, H. P. Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man. J. Clin. Endocrinol. Metab. 71: 1567, 1990.
18. Stouthard, J. M. L., van der Poll, T., Endert, E., Bakker, P. J., Veenhof, C. H., Sauerwein, H. P., and Romijn, J. A. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J. Clin. Endocrinol. Metab. 79: 1342, 1994.
19. Bremner, W. J., Abreu, R., Stockigt, J. R., DeKretser, D. M., and Burger, H. G. Pituitary-thyroid responses to 4-hour constant infusions of thyrotropin releasing hormone in man. J. Clin. Endocrinol. Metab. 45: 981, 1977.
20. Holaday, J. W., D'Amato, R. J., and Faden, A. I. Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock. Science 213: 216, 1981.
21. Chopra, I. J., Solomon, D. H., Chua Teco, G. N., and Eisenberg, J. B. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 251: 407, 1982.
22. Moley, J. F., Ohkawa, M., Chaudry, I. H., Clemens, M. G., and Baue, A. E. Hypothyroidism abolishes the hyperdynamic phase and increase susceptibility to sepsis. J. Surg. Res. 36: 265, 1984.
23. Palazzo, M. G., and Suter, P. M. Delivery dependent oxygen consumption in patients with septic shock: Daily variations, relationship with outcome and the sick-euthyroid syndrome. Intensive Care Med. 17(6): 325, 1991.
24. 3 administration on Na-K,ATPase in the rat skeletal muscle. Metabolism 41(9): 995, 1992.
25. +)-ATPase in rat heart during different phases of sepsis. Circ. Shock 41: 19, 1993.
26. Liggett, S. B., Shah, S. D., and Cryer, P. E. Increased fat and skeletal muscle β-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis. J. Clin. Invest. 83: 803, 1989.
27. Orlowski, J. P., and Spees, E. K. Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant. Proc. 25(1): 1535, 1993.
28. Novitzky, D., Cooper, D. K. C, and Zuhdi, N. Triiodothyronine therapy in the cardiac transplant recipient. Transplant. Proc. 20(5) (Suppl.7): 65, 1988.
29. Novitzky, D., Cooper, D. K. C., and Reichart, B. Preservation of organs and acute tubular necrosis. Transplant. Proc. 19(1): 2037, 1987.
30. Novitzky, D., Cooper, D. K. C., Morrell, D., and Isaacs, S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 45(1): 32, 1988.
31. Garcia-Fages, L. C., Cabrer, C., Valero, R., and Manyalich, M. Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors. Transplant. Proc. 25(6): 3038, 1993.
32. Klein, I. Thyroid hormone and the cardiovascular system. Am. J. Med. 88: 631, 1990.
33. Ishikawa, T., Chijiwa, T., Hagiwara, M., Mamiya, S., and Hidaka, H. Thyroid hormones directly interact with vascular smooth muscle strips. Mol. Pharmacol. 35: 760, 1989.
34. Baker, C. H., and Sutton, E. T. Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am. J. Physiol. 264: H1118, 1993.